FIELD: medicine.
SUBSTANCE: invention relates to medical diagnostics, can be used for prediction of non-developing pregnancy. Method for prediction of non-developing pregnancy involves RNA isolation from cervical channel epithelial cells at 6–10 weeks of pregnancy, reverse transcription to obtain cDNA, TLR2, TLR10 and IDO expression by a quantitative polymerase chain reaction, age estimate of menarche and prognosis of developing non-developing pregnancy on the basis of equations obtained by discriminant analysis: -for non-developing pregnancy: y1=40.13+(-1058.06*x1)+56.10*x2+0.01*x3+5.8*x4; -for progressing pregnancy: y2=-32.0163+80.7501*x1+24.1316*x2+0.0080*x3+5.1076*x4, where x1 TLR2 mRNA expression level (relative units), x2 TLR10 mRNA expression level (relative units), x3 is an IDO mRNA expression level (po units), x4 – age of menarche, at that, if y1 greater than y2, a high risk of developing a miscarriage is predicted, and if y1 less than y2, normal course of pregnancy is predicted.
EFFECT: what is presented is a method for prediction of non-developing pregnancy.
1 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EARLY PREDICTION OF HABITUAL MISCARRIAGE | 2014 |
|
RU2592204C1 |
METHOD FOR PREDICTING NON-DEVELOPING PREGNANCY ASSOCIATED WITH CHROMOSOMAL ABNORMALITIES OF THE EMBRYO | 2021 |
|
RU2760499C1 |
METHOD FOR PREDICTION OF NON-DEVELOPING PREGNANCY IN NORMAL EMBRYO KARYOTYPE | 2021 |
|
RU2766750C1 |
METHOD FOR PREDICTION OF PREGNANCY COURSE IN UROGENITAL INFECTION | 2019 |
|
RU2720135C1 |
METHOD FOR ASSESSMENT OF SEVERITY OF INFECTIOUS PROCESS IN UROGENITAL INFECTION IN PREGNANT WOMEN | 2019 |
|
RU2715626C1 |
METHOD OF PREDICTING RISK OF LATE SPONTANEOUS MISCARRIAGE | 2023 |
|
RU2812645C1 |
METHOD OF PREDICTION OF INCOMPLETE PREGNANCY IN FIRST HALF OF PREGNANCY IN WOMEN WITH UROGENITAL INFECTION | 2015 |
|
RU2607659C1 |
METHOD FOR ASSESSMENT OF MUCOSAL IMMUNITY IN UROGENITAL INFECTION IN PREGNANT WOMEN | 2019 |
|
RU2715618C1 |
METHOD OF PREDICTING MISCARRIAGE BY ASSESSING VASCULAR ENDOTHELIAL GROWTH FACTOR AND PROSTAGLANDIN F2Α IN THE PERIPHERAL BLOOD OF PREGNANT WOMEN DURING EXACERBATION OF CYTOMEGALOVIRUS INFECTION IN THE FIRST TRIMESTER | 2023 |
|
RU2800311C1 |
METHOD OF MANAGEMENT OF PREGNANCY WITH INFECTIOUS PATHOLOGY OF UROGENITAL TRACT | 2017 |
|
RU2649127C1 |
Authors
Dates
2019-05-24—Published
2018-11-22—Filed